| Name | Title | Contact Details |
|---|
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
CareSite Pharmacy is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Whip Mix is the one resource that helps the Dental Profession achieve its goals of high quality, less invasive patient care, reduced chair time and increased operating efficiencies.
Community Care Behavioral Health Organization is a Pittsburgh, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Fitzgerald Industries International is a Acton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.